Vladimir GAUTHIER is national winner of the PEPITE competition for young creators of innovative companies

Entrepreneurial PhD at FEMTO-ST, Vladimir Gauthier is developing a company project on the microrobotic sorting of biological cells, which has received national price !

Created in 2014, the PEPITE Prize was created by the Ministry of Higher Education, Research and Innovation to encourage entrepreneurship among young people in higher education, to strengthen support for the creation of innovative companies and to better support the development of projects that emerge with the support of PEPITE. In 2019, Bpifrance is a partner in this initiative and is co-organizing the Prize.

Selected as the national winner of PEPITE, representative of the Burgundy-Franche-Comté region, Vladimir Gauthier brilliantly put forward his "Cell-Select" business creation project during the BIG (BPI Inno Generation) event organized by Bpifrance on Thursday, October 10 in Paris. Currently post-doctoral fellow and entrepreneur, Vladimir Gauthier is preparing to create his start-up within FEMTO-ST Institute where he has developed a microrobotic technological tool to greatly improve the quality of continuous flow cell sorting.

This new technology offers an innovative system for selecting and isolating target immune cells, lymphocytes (white blood cells), which are capable of attacking tumor cells after being cultured and re-injected into the patient. However, these lymphocytes are rare in a blood sample and their rapid and accurate sorting is necessary so that physicians can optimize immunotherapy treatments to effectively fight cancer. The micro robot developed by "CellSelect" will thus make it possible to sort 1 million cells per hour with a degree of precision never before achieved.

FEMTO-ST is launching its support program for MSCA Postdoctoral Fellowships applications !
The Boostcamp is a two-day intensive workshop aimed at helping international researchers develop a strong application for the 2025 Marie Skłodowska-Curie Postdoctoral Fellowship.
Read more
Using artificial intelligence to collect agricultural data
ANR OCOD project combines intelligent sensors, drones and optimization for data collection in constrained natural environments
Read more
A European project to prevent perineal tears
PELVITRACK offers a predictive tool for patricians as part of an interdisciplinary European consortium involving FEMTO-ST.
Read more
Best Paper Award at BIOSTEC 2025
The work of Ouassim Boukhennoufa and his team combines AI and image optimization in nuclear medicine for more accurate and earlier detection of parathyroid anomalies.
Read more
Kagomé structures for quantum technologies
Quantum technologies open up promising prospects, but require the development of new materials with remarkable properties.
Read more
Launch of the European SAMI project for energy-free intelligent sensors
A major scientific and technological collaboration between Silmach and FEMTO-ST in the field of intelligent, autonomous sensors kicks off on January 30.
Read more
RENATECH 2024 PhD AWARD
Adria Grabulosa is rewarded for his work on 3D printed circuits using an original two-photon optical additive manufacturing technique.
Read more
Elsevier article award at BFAS 2024
Artificial intelligence applied to the electroerosion machining process : Loïc Guiziou1, Emmanuel Ramasso1, Sébastien Thibaud1 et Sébastien Denneulin2 won second prize for best paper at the 8th International Conference on Belief Functions.
Read more
Tribute to our colleague Sarah Benchabane
The CNRS and the university community of Bourgogne Franche-Comté are in mourning following the death of Sarah Benchabane, Director of Research at the CNRS and internationally renowned researcher in phononics, affiliated to the FEMTO-ST laboratory.
Read more
Does the i-motif structure of DNA exist in the cell?
As part of an interdisciplinary project involving FEMTO-ST, a new scientific study is reopening the debate on the very existence of these structures in DNA and their potential therapeutic interest in cell biology for the treatment of certain cancers.
Read more